Christopher Causey, Director at UNITED THERAPEUTICS Corp (UTHR), sold 5,000 shares at $236.79 ($1.2M) on 2022-06-27, disclosed to the SEC on 2022-06-28.
Seasonal sale ($1.2M) by Director — this insider has traded UTHR in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| UTHR | SELL | 2026-02-25 | $520K | — | Filing → |
| UTHR | SELL | 2026-01-06 | $510K | — | Filing → |
| UTHR | SELL | 2026-01-05 | $500K | — | Filing → |